Page Comparison

https://www.nature.com/articles/s41386-024-01973-5

https://doi.org/10.1080/00952990.2024.2360984

Image Added

Characterizing the Cannabis Withdrawal Trajectory in Men With Cannabis and Tobacco Co-Use: A Preliminary Study

Zac Yeap, Lyne Baaj, Tony George, Romina Mizrahi, Rachel Rabin

Cannabis and tobacco co-use is prevalent, and individuals who co-use have elevated cannabis relapse rates compared with those using cannabis alone. Research demonstrates that individuals who co-use experience greater cannabis withdrawal severity, a strong predictor of cannabis relapse…

https:/

/journals.sagepub.com/doi/abs/10.1177/07067437241289964

Image Added

Image Added Training in Substance Use Disorders, Part 2: Updated Curriculum Guidelines

David Crockford, Anees Bahji, Christian Schutz, Jennifer Brasch, Leslie Buckley,
Marlon Danilewitz, Simon Dubreucq, Michael Mak, Tony George.

Training in the management of substance use disorders (SUDs) in psychiatry remains disproportionately limited in psychiatric residency training programs, compared with…

Image Added

Image Added Functional and structural effects of repetitive transcranial magnetic stimulation (rTMS) for the treatment of auditory verbal hallucinations in schizophrenia: A systematic review

Dhvani Mehta, Salsabil Siddiqui, Heather Ward, Vaughn Steele, Godfrey Pearlson, Tony George

Auditory verbal hallucinations (AVH) are a disabling symptom for people with schizophrenia (SCZ), and do not always respond to antipsychotics. Repetitive transcranial magnetic stimulation (rTMS) has shown efficacy for medication-refractory AVH…

Image Added

Image Added Factors to guide the use of extended-release buprenorphine formulations for specific patient populations

Ari Cuperfain, Gali Katznelson, Tianna Costa, Patrick Wong, Narges Beyraghi, Tony George, Michelle Lofwall, Nitin Chopra

Opioid agonist therapy is first line in the management of opioid use disorder (OUD). Many guidelines support buprenorphine as the optimal treatment due to its preferred safety…

Image Added

Image Added Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies

Samantha Johnstone, Maryam Sorkhou, Molly Zhang, Sarah Dermody, Rachel Rabin, Tony George.

Background: People with schizophrenia have high rates of cannabis use disorder (CUD) as well as co-use of tobacco…

Image Added

Peer-administered Naloxone for Preventing Opioid Overdose: A Scoping Review

Kayla Dlugos, Kateryna Maksyutynska, Luke Kyne, Tianna Costa, Tony George

Peer administration of the opioid receptor antagonist naloxone is an important public health initiative with the potential to decrease opioid-related deaths. There is evidence in support of opioid overdose education and peer-administered naloxone; however, the outcomes of peer…

https://journals.sagepub.com/doi/abs/10.1177/07067437241231128

Image Added

Effects of open access publishing on article metrics in Neuropsychopharmacology

Briana Chen, Taylor Custis, Lisa Monteggia & Tony George 

Neuropsychopharmacology (NPP) offers the option to publish articles in different tiers of an open access (OA) publishing system: Green, Bronze, or Hybrid…

Image Added

A systematic review and meta-analysis of neuromodulation therapies for substance use disorders

Dhvani Mehta, Angela Praecht, Heather Ward, Marcos Sanches, Maryam Sorkhou, Victor Tang, Vaughn Steele, Colleen Hanlon & Tony George.

While pharmacological, behavioral and psychosocial treatments are available for substance use disorders (SUDs), they are not always effective or well-tolerated…

Image Added

Image Added Birth, cognitive and behavioral effects of intrauterine cannabis exposure in infants and children: A systematic review and meta-analysis

Maryam Sorkhou, Daisy Singla, David Castle & Tony George.

Delta9-tetrahydrocannabinol (THC), the principal psychoactive component of cannabis, has been implicated in affecting fetal neurodevelopment…

Image Added

Identifying clinical predictors of response to repetitive transcranial magnetic stimulation for smoking cessation: Secondary analysis of a multicenter RCT

Victor Tang, Laurie Zawertailo, Peter Selby, Abraham Zangen, Dhvani Mehta, Tony George, Bernard Le Foll, Kristina Gicas. Matthew Sloan, Scott Veldhuizen

Tobacco smoking remains a leading cause of morbidity and mortality worldwide. While evidence-based treatments exist for nicotine dependence, many patients do not respond to or cannot tolerate them. Repetitive Transcranial Magnetic Stimulation (rTMS) is a novel, non-invasive neuromodulation treatment that stimulates parts of the brain involved in addiction [1]. Recently, the Brainsway H4 deep TMS coil was cleared by the FDA and Health Canada for the treatment for…

https://doi.org/10.1007/s40429-024-00541-7

https://link.springer.com/article/10.1007/s40429-023-00533-z

https://doi.org/10.1007/s40429-023-00532-0